Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ALXO | D | ALX Oncology Holdings Inc. | -3.77 | |
ACHL | C | Achilles Therapeutics plc | 5.87 | |
ADAG | D | Adagene Inc. | 11.76 | |
ADAP | C | Adaptimmune Therapeutics plc | 0.32 | |
ACET | D | Adicet Bio, Inc. | 0.43 | |
ANL | C | Adlai Nortye Ltd. | -2.86 | |
AMAM | A | Ambrx Biopharma Inc. | 0.00 | |
RCUS | C | Arcus Biosciences, Inc. | 4.56 | |
BCEL | F | Atreca, Inc. | 3.20 | |
AVTX | D | Avalo Therapeutics, Inc. | 431.16 |
Related Industries: Biotechnology Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | C | Loncar Cancer Immunotherapy ETF | 1.85 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 1.42 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 1.31 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 0.99 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 0.94 |
Compare ETFs
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles